vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and MARCUS CORP (MCS). Click either name above to swap in a different company.

Cellebrite DI Ltd. is the larger business by last-quarter revenue ($292.2M vs $193.5M, roughly 1.5× MARCUS CORP). Cellebrite DI Ltd. produced more free cash flow last quarter ($60.8M vs $26.4M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 18.2%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Marcus & Millichap, Inc. is an American company that provides real estate brokerage, mortgage brokerage, research, and advisory services in the U.S. and Canada in the field of commercial property. It popularized the practice of listing properties exclusively with one brokerage firm. The company has over 1,800 employees in more than 80 offices across the U.S. and Canada.

CLBT vs MCS — Head-to-Head

Bigger by revenue
CLBT
CLBT
1.5× larger
CLBT
$292.2M
$193.5M
MCS
More free cash flow
CLBT
CLBT
$34.4M more FCF
CLBT
$60.8M
$26.4M
MCS
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
18.2%
MCS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CLBT
CLBT
MCS
MCS
Revenue
$292.2M
$193.5M
Net Profit
$-302.3M
Gross Margin
84.6%
Operating Margin
14.1%
0.9%
Net Margin
-103.5%
Revenue YoY
2.8%
Net Profit YoY
EPS (diluted)
$-1.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
MCS
MCS
Q4 25
$193.5M
Q3 25
$292.2M
$210.2M
Q2 25
$220.8M
$206.0M
Q1 25
$89.6M
$148.8M
Q4 24
$188.3M
Q3 24
$232.1M
$232.7M
Q2 24
$185.3M
$176.0M
Q1 24
$71.2M
$138.5M
Net Profit
CLBT
CLBT
MCS
MCS
Q4 25
Q3 25
$-302.3M
$16.2M
Q2 25
$36.9M
$7.3M
Q1 25
$-71.4M
$-16.8M
Q4 24
$986.0K
Q3 24
$23.3M
Q2 24
$-95.2M
$-20.2M
Q1 24
$-40.6M
$-11.9M
Gross Margin
CLBT
CLBT
MCS
MCS
Q4 25
Q3 25
84.6%
Q2 25
84.1%
Q1 25
85.2%
Q4 24
Q3 24
83.5%
Q2 24
84.1%
Q1 24
82.6%
Operating Margin
CLBT
CLBT
MCS
MCS
Q4 25
0.9%
Q3 25
14.1%
10.8%
Q2 25
12.1%
6.3%
Q1 25
10.3%
-13.7%
Q4 24
-1.2%
Q3 24
7.9%
14.1%
Q2 24
11.7%
1.3%
Q1 24
0.2%
-12.0%
Net Margin
CLBT
CLBT
MCS
MCS
Q4 25
Q3 25
-103.5%
7.7%
Q2 25
16.7%
3.6%
Q1 25
-79.7%
-11.3%
Q4 24
0.5%
Q3 24
10.0%
Q2 24
-51.4%
-11.5%
Q1 24
-57.0%
-8.6%
EPS (diluted)
CLBT
CLBT
MCS
MCS
Q4 25
Q3 25
$-1.50
Q2 25
$0.15
Q1 25
$-0.36
Q4 24
Q3 24
$-0.35
Q2 24
$-0.48
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
MCS
MCS
Cash + ST InvestmentsLiquidity on hand
$191.7M
$23.4M
Total DebtLower is stronger
$159.0M
Stockholders' EquityBook value
$336.0M
$457.4M
Total Assets
$690.6M
$1.0B
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
MCS
MCS
Q4 25
$23.4M
Q3 25
$191.7M
$7.4M
Q2 25
$326.1M
$14.9M
Q1 25
$191.7M
$11.9M
Q4 24
$40.8M
Q3 24
$189.5M
$28.4M
Q2 24
$178.6M
$32.8M
Q1 24
$189.5M
$17.3M
Total Debt
CLBT
CLBT
MCS
MCS
Q4 25
$159.0M
Q3 25
$162.0M
Q2 25
$179.9M
Q1 25
$198.9M
Q4 24
$159.1M
Q3 24
$173.1M
Q2 24
$175.7M
Q1 24
$169.8M
Stockholders' Equity
CLBT
CLBT
MCS
MCS
Q4 25
$457.4M
Q3 25
$336.0M
$454.3M
Q2 25
$408.4M
$448.4M
Q1 25
$336.0M
$441.8M
Q4 24
$464.9M
Q3 24
$34.2M
$462.3M
Q2 24
$-40.2M
$449.4M
Q1 24
$34.2M
$459.3M
Total Assets
CLBT
CLBT
MCS
MCS
Q4 25
$1.0B
Q3 25
$690.6M
$1.0B
Q2 25
$787.4M
$1.0B
Q1 25
$690.6M
$1.0B
Q4 24
$1.0B
Q3 24
$532.9M
$1.0B
Q2 24
$556.6M
$1.1B
Q1 24
$532.9M
$1.0B
Debt / Equity
CLBT
CLBT
MCS
MCS
Q4 25
0.35×
Q3 25
0.36×
Q2 25
0.40×
Q1 25
0.45×
Q4 24
0.34×
Q3 24
0.37×
Q2 24
0.39×
Q1 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
MCS
MCS
Operating Cash FlowLast quarter
$66.2M
$48.8M
Free Cash FlowOCF − Capex
$60.8M
$26.4M
FCF MarginFCF / Revenue
20.8%
13.6%
Capex IntensityCapex / Revenue
1.8%
11.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$989.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
MCS
MCS
Q4 25
$48.8M
Q3 25
$66.2M
$39.1M
Q2 25
$53.5M
$31.6M
Q1 25
$10.0M
$-35.3M
Q4 24
$52.6M
Q3 24
$58.2M
$30.5M
Q2 24
$24.6M
$36.0M
Q1 24
$12.5M
$-15.1M
Free Cash Flow
CLBT
CLBT
MCS
MCS
Q4 25
$26.4M
Q3 25
$60.8M
$18.2M
Q2 25
$47.5M
$14.7M
Q1 25
$8.5M
$-58.3M
Q4 24
$27.1M
Q3 24
$55.3M
$12.0M
Q2 24
$21.0M
$16.1M
Q1 24
$11.4M
$-30.5M
FCF Margin
CLBT
CLBT
MCS
MCS
Q4 25
13.6%
Q3 25
20.8%
8.7%
Q2 25
21.5%
7.1%
Q1 25
9.5%
-39.2%
Q4 24
14.4%
Q3 24
23.8%
5.2%
Q2 24
11.3%
9.2%
Q1 24
16.0%
-22.0%
Capex Intensity
CLBT
CLBT
MCS
MCS
Q4 25
11.6%
Q3 25
1.8%
9.9%
Q2 25
2.7%
8.2%
Q1 25
1.7%
15.5%
Q4 24
13.5%
Q3 24
1.3%
7.9%
Q2 24
1.9%
11.3%
Q1 24
1.5%
11.1%
Cash Conversion
CLBT
CLBT
MCS
MCS
Q4 25
Q3 25
2.41×
Q2 25
1.45×
4.32×
Q1 25
Q4 24
53.31×
Q3 24
1.31×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

MCS
MCS

Theatres$123.1M64%
Concessions$51.0M26%
Food And Beverage$21.2M11%

Related Comparisons